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The robust and diversely useful isoindoline nitroxide 5-carboxy-
1,1,3,3-tetramethylisoindolin-2-yloxyl 1 (CTMIO) has previously
been synthesised in low to moderate yields (15% overall) from 
phthalic anhydride 3. Recent interest in its biological potential as a
potent antioxidant and in other areas has seen an increased demand 
for its production. Herein, three new synthetic routes to CTMIO are 
presented and their efficiencies assessed. 
Two routes, via the nitrile 9 and the formyl 11 intermediates 
derive from 5-bromo-1,1,3,3-tetramethylisoindoline 6. The third 
approach starts from the readily accessable starting material, 4-
methylphthalic anhydride 12, and proceeds via a methylarene 
oxidation with potassium permanganate. The three new 
approaches yield CTMIO in comparable overall yields (15-18%) 
however, the synthetic efficiency and number of steps are most 
improved when employing the nitrile intermediate. 
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Introduction 
5-Carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl 1 (CTMIO, 
Figure 1),[1] is an isoindoline-based nitroxide that displays low 
cellular toxicity and high sensitivity in electron paramagnetic 
resonance (EPR).[2] Unlike many other isoindoline-based nitroxides, 
the presence of the water solubilizing carboxy group on CMTIO 
has facilitated its use as a potent antioxidant in a number of 
biological models and systems.[3]  
In the autosomal recessive genetic childhood disorder Ataxia 
telangiectasia (A-T), CTMIO attenuates oxidative stress in A-T 
cells significantly more than known antioxidants such as vitamin E 
or Trolox.[3b] These findings demonstrated exciting prospects for 
CTMIO to be employed as a potential therapeutic intervention 
against A-T progression.[4] CTMIO has also been shown to act as 
an almost-stoichiometric equivalent scavenger of protein radicals 
capable of providing extensive amelioration of both oxidation 
reactions and the associated damage.[5] As an efficient protein 
derived radical scavenger, CTMIO can inhibit the myeloperoxidase 
(MPO)-mediated hypochlorous acid production system.[6] This 
system is known to play a key role in most inflammatory and 
neurodegenerative disorders and is implicated in the pathogenesis 
and progression of more than fifty human disorders. 
 Synthetically, CTMIO has served as a useful precursor to 
isoindoline functionalised systems such as profluorescent 
nitroxides[7] based on the porphyrin fluorophore[8] and nitroxide-
based adenosine receptor agonists.[9] CTMIO has also been 
reported as a potential redox mediator for dye-sensitised solar 
cells.[10] 
 
Figure 1. Common nitroxide ring classes: (a) piperidine, (b) pyrrolidine and 
(c) isoindoline. 
Despite the synthetic versatility and range of potential 
applications of CTMIO, further exploratory work is limited by the 
lack of commercial availability of this nitroxide and its laborious 
synthesis. To the best of our knowledge, there is currently only one 
reported synthetic route to CTMIO (Scheme 1).[1a] The six step 
synthesis has an overall yield of 15% beginning from the 
inexpensive phthalic anhydride 3.  
 
Scheme 1. Reagents and conditions: (i) BnNH2, AcOH, reflux, 1 h; (ii) 
MeMgI, PhMe, reflux, 4 h; (iii) Br2, AlCl3, CH2Cl2, 0 ºC, 1 h; (iv) n-BuLi,  
THF, CO2, -78 ºC, 10 min; (v) H2O/MeOH, NaHCO3, Na2WO4·H2O, H2O2, 
room temp. , 48 h. 
The key step in this synthesis involves the dilithiation of 5-
bromo-1,1,3,3-tetramethylisoindoline 6 and subsequent quenching 
of the resuting dianion with carbon dioxide. This produces the 
zwitterion 7 in situ, which is quite difficult to handle and is 
subsequently converted immediately to 1 via oxidation with 
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sodium tungstate and H2O2. It must be noted that the conversion of 
bromoamine 6 to zwitterion 7 can be problematic, as it requires the 
use of anhydrous CO2. The addition of CO2 is normally achieved 
by treating a THF solution of the dilithiated species with dry ice 
pellets which can retain varying degrees of water. Approaches 
involving the bubbling of gaseous CO2 through THF solutions of 
dilithiated species are often hindered by a gradual thickening of the 
solution which impacts on mass and heat transfer and restricts 
scale-up.  
Trace amounts of water can lead to various side-reactions, most 
notably the formation of 1,1,3,3-tetramethylisoindoline which 
gives rise to nitroxide 2 following oxidation. The highest 
documented yield of CTMIO 1 over the two steps is 62%, however 
this remains difficult to reproduce in most cases and an average 
yield for these two steps is 56%.  
In light of this, we present herein, three alternative syntheses of 
CTMIO 1, developed in an attempt to improve the yield and 
provide greater practical synthetic utility. The first two routes 
employ the bromoamine precursor 6 to access CTMIO 1 via either 
the nitrile derivative 9 or its formyl counterpart 11. The final route 
utilises commercially available 4-methylphthalic anhydride 12 as 
the starting material to produce a suitable methylarene derivative 
16 that may be oxidized in moderate yield (65%) to the desired 
carboxylic acid.  
Results and Discussion 
Given the aforementioned low yields of CTMIO illustrated in 
Scheme 1, it was anticipated that successful synthesis of the nitrile 
derivative 8, via the known common precursor 6 (synthesised in 
24% yield in 3 steps from phthalic anhydride), could provide an 
improved synthetic route to CTMIO via hydrolysis. Hence, the 
copper(I)-catalyzed cyanation of arylbromides reported by 
Schareina et al. was employed.[11] This method employs potassium 
hexacyanidoferrate(II) (K4[Fe(CN)6]), as the nitrile source. 
Treatment of compound 5 with K4[Fe(CN)6] in the presence of 
catalytic CuI and 1-butylimidazole at elevated temperature 
afforded a mixture of 8 and a 1-butylimidazole complex. A mild 
peroxyl oxidation of 8 using m-chloroperoxybenzoic acid (m-
CPBA) afforded the corresponding nitroxide derivative 9 (78% 
over 2 steps). A base-catalyzed hydrolysis of 9 yielded the desired 
CTMIO in 74% from 6 (18% yield from 3, Scheme 2). 
 
Scheme 2. Reagents and conditions: (i) K4[Fe(CN)6].3H2O, CuI, 1-
butylimidazole, o-xylene, 180 ºC, 4 d, sealed vessel; (ii) m-CPBA, CH2Cl2, 
0 ºC 1 h to room temp., 6 h.; (iii) NaOH, H2O, EtOH, reflux, 16 h. 
The second synthetic route proceeded via the aldehyde 
derivative 5-formyl-1,1,3,3-tetramethylisoindoline 10. This 
protocol provided a milder, yet facile and high yielding 
methodology for CTMIO from 4 which is quantitatively converted 
to the formyl derivative 10 via quenching of the dilithiated 
isoindoline with anhydrous N,N-dimethylformamide. The nitroxide 
11 was obtained via mCPBA oxidation. Subsequent oxidation of 11 
with a AgNO3/NaOH solution yielded CTMIO in 66% yield from 6 
(15% yield from 3, Scheme 3). 
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Scheme 3. Reagents and conditions: (i) n-BuLi, THF, DMF, -78 ºC, 1 h to 
room temp. 3 h; (ii) m-CPBA, CH2Cl2, 0 ºC, 1 h to room temp., 6 h; (iii) 
AgNO3, NaOH, H2O, room temp., 6 h. 
An alternative starting material for the preparation of CTMIO 1 
is 4-methylphthalic anhydride 12, which holds significant potential 
due to its low cost as well as its tolerance to multiple synthetic 
transformations (Scheme 4). Accordingly, N-benzyl-5-methyl-
phthalimide 13 was obtained in excellent yield (98%) when an 
acetic acid solution of 12 was treated with 1.5 equivalents of N-
benzylamine. Exhaustive methylation of 13 with a six-fold excess 
of freshly prepared methylmagnesium iodide furnished compound 
14 in the modest yield (34%) that is typical for these reactions. 
Quantitative debenzylation via hydrogenation using catalytic 
palladium on activated charcoal, and subsequent peroxyl oxidation 
gave the nitroxide 16 in high yield (95%).  
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Scheme 4. Reagents and conditions: (i) BnNH2, AcOH, reflux, 1 h; (ii) 
MeMgI, PhMe, reflux, 4 h; (iii) H2 (50 psi), Pd/C, AcOH, room temp., 4 h; 
(iv) m-CPBA, CH2Cl2, 0 ºC, 1 h to room temp., 6 h.; (v) a. H2, Pd/C, THF, 
room temp. , 20 min., b. AcCl, Et3N, 0 ºC, 30 min. to room temp., 1 h; (vi) 
MgSO4, KMnO4(aq), 70 ºC, 1 d to room temp., i-PrOH, 8 h; (vii) NaOH, 
EtOH, 0 ºC, 30 min. to room temp., 8 h. 
Previous studies have demonstrated that isoindoline-type 
nitroxides are susceptible to decomposition upon permanganate 
oxidation.[12] Consequently, protection of the nitroxide moiety of 
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16 was first necessary before oxidation could be attempted. N-
acetylation and N-deacetylation steps are well documented in the 
literature and thus, the acetate group provides a useful protecting 
group for the nitroxide moiety.[13] Accordingly, the nitroxide 16 
was efficiently reduced to the corresponding hydroxylamine with 
hydrogen gas and then acetylated in situ with acetyl chloride in the 
presence of triethylamine to give compound 17 (95%). Potassium 
permanganate side chain oxidation of the methyl group attached to 
the aromatic ring afforded the corresponding carboxylic acid 13 in 
moderate yield (65%).[14] This acid was readily deprotected to give 
CTMIO by stirring overnight in a dilute sodium hydroxide solution. 
The overall yield of CTMIO 1 from this route was 17%. 
Of the three alternative syntheses reported, the formation of 
CTMIO 1 via the nitrile intermediate 8 ultimately yields CTMIO in 
the best overall yield (18% over 6 steps, calculated from starting 
material 3). The yields of 1 via the formyl route (14% overall) and 
the original method (13-15% overall) were slightly lower. The 
route starting from the readily available precursor 12 and 
proceeding by oxidation of the methyl group attached to the 
aromatic ring gave an overall yield of 17% (over 7 steps) which is 
comparable to the other syntheses of CTMIO reported herein. 
When comparing these results to the previously reported synthesis 
of CTMIO (Scheme 1, 13-15% overall) some synthetic 
improvement has been achieved, particularly within the Grignard 
reaction. However, protection and deprotection of the nitroxide in 
the later stages increases the number of steps and the imposes 
practical limitations on the synthesis. 
Conclusions 
We have reported three optimized protocols for the synthesis of 
the versatile isoindoline nitroxide, CMTIO 1. From the precursor 
5-bromo-1,1,3,3-tetramethylisoindoline 6, CTMIO can be accessed 
either via the nitrile or the formyl derivatives, each involving three  
alternative high yielding and straightforward reaction methods. 
CTMIO can also be formed from 4-methylphthalic anhydride 12 
with the key transformation involving oxidation of the methyl side 
chain on the aromatic ring. Variable yields in the original synthetic 
sequence brought about by the presence of water carried through in 
the CO2 addition step are avoided with all three new synthetic 
strategies. We recommend future large scale syntheses of CTMIO 
be performed using the nitrile method, where a small but 
significant increase above the original reported yield can be 
achieved. In addition, technically demanding low-temperature 
reactions, hazardous butyllithium reagents and divergent protecting 
group requirements are eliminated in this route. 
Experimental Section 
General methods 
All air-sensitive reactions were carried out under ultra-high purity argon. 
Diethyl ether and toluene were dried by storage with sodium wire. 
Tetrahydrofuran (THF) was freshly distilled from sodium benzophenone 
ketal and methylene chloride freshly distilled from calcium hydride. 
Triethylamine was dried by storage with potassium hydroxide. Crystalline 
K4[Fe(CN)6]·3H2O was ground to a fine powder and then dried at 80°C at 
0.5 Torr for 10 hr. All other reagents were purchased from commercial 
suppliers and used without further purification. 1H and 13C NMR spectra 
were recorded with a Bruker Avance 400 MHz or Varian 400 MHz 
spectrometers and referenced to the relevant solvent peak. HPLC were 
performed on HP Agilent 1100 HPLC instrument. HRMS were recorded on 
an Agilent accurate mass QTOF LC-MS. Formulations were calculated in 
the elemental analysis programs of Mass Lynx 4.0 or Micromass Opus 3.6. 
Fourier transform infrared (FTIR) spectra were recorded on a Nicolet 870 
Nexus Fourier Transform Infrared Spectrometer equipped with a DTGS 
TEC detector and an ATR objective. Melting points were measured using 
Differential Scanning Calorimetry (DSC). Thermograms were recorded on 
a TA Instruments (New Castle, DE, USA) DSC-100 under a nitrogen flow 
of 50 mL min-1. Sealed aluminium hermetic pans containing approximately 
1 mg of sample were used in each case with a heating rate of 2 C min-1. 
Compounds 4-6, 10 and 12 were synthesized as previously described.[1, 12, 15]  
 
5-Cyano-1,1,3,3-tetramethylisoindol-2-yloxyl (9) 
m-Chloroperoxybenzoic acid (864 mg, 2.96 mmol, 1.3 equiv., ≤77%) was 
added to an ice-cold solution of 5-cyano-1,1,3,3-tetramethylisoindoline 8 
and 1-butylimidazole complex (458 mg, 2.28 mmol, 1.0 equiv.) in dry 
methylene chloride (20 mL). The resulting solution stirred for 1 h at 0 oC. 
The cooling bath was removed and stirring was continued at room 
temperature for a further 5 h, with additional methylene chloride added to 
dissolve the formed precipitate. The bright yellow organic phase was 
washed successively with HCl (0.5 M aqueous solution), NaOH (2 M 
aqueous solution) and brine and dried over anhydrous Na2SO4. The filtrate 
was concentrated in vacuo and the resultant solid recrystallised from 
cyclohexane to yield compound 9 as a bright yellow solid (330 mg, 78% 
from 6). m.p. 127 oC. HRMS (ES): m/z (%) = 217 (80, [M+2H]+). Calc. for 
C13H16N2O [M+2H]+): 217.1341; found 217.1281. ATR-FTIR: vmax= 2227 
(m, s, C≡N).  
  
5-Carboxy-1,1,3,3-tetramethylisoindol-2-yloxyl (1) from 9 
A suspension of 5-cyano-1,1,3,3-tetramethylisoindol-2-yloxyl 9 (150 mg, 
698 umol, 1.0 equiv.) in NaOH (3 mL, 2 M aqueous solution) and EtOH 
(0.6 mL) was heated at reflux for 16 h at 105 oC. The reaction was cooled 
to room temperature, diluted with water (5 mL), washed with Et2O and then 
acidified to pH 1 with HCl (2 M aqueous solution). The acidic aqueous 
layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
washed with brine, dried over anhydrous Na2SO4 and filtered. The filtrate 
was concentrated in vacuo and recrystallised from MeCN to obtain 1 as a 
yellow solid (155 mg, 95%). m.p. 211 oC (Lit. 214-218 oC).[1b] 
 
5-Carboxy-1,1,3,3-tetramethylisoindol-2-yloxyl (1) from 11 
NaOH (29.3 mg, 733 umol, 4.0 equiv.) and AgNO3 (62.3 mg, 366.5 umol, 
2.0 equiv.) were added to water (3 mL) and stirred at room temperature for 
30 min. A solution of 5-formyl-1,1,3,3-tetramethylisoindolin-2-yloxyl 11 
(40 mg, 183.3 umol, 1 equiv.) in ethanol (1.5 mL) was added to the 
resulting mixture and the reaction mixture stirred for 6 h. The solution was 
acidified (pH < 2) by careful addition of HCl (2 M aqueous solution). The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined ether 
layers washed with brine, dried over anhydrous Na2SO4 and the filtrate 
concentrated in vacuo and recrystallised from MeCN to give 1 as a yellow 
solid (31 mg, 72%). m.p. 211 oC (Lit. 214-218 oC).[1b] 
 
1,1,3,3,5-Pentamethylisoindoline (15) 
A mixture of N-benzyl-1,1,3,3,5-pentamethylisoindoline 14 (5.0 g, 17.91 
mmol, 1.0 equiv.) and palladium (476 mg, 448 umol, 0.025 equiv., 10% on 
carbon) in glacial acetic acid (120 mL) was shaken under an atmosphere of 
hydrogen gas (50 psi) for 4 h. The reaction mixture was then filtered 
through Celite and concentrated in vacuo. The resulting residue was 
dissolved in diethyl ether (250 mL) and washed successively with NaOH (2 
M aqueous solution) and brine. The organic layer was dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo to afford white crystals of 15 
(3.32 g, 98%), which was used in subsequent reactions without further 
purification. m.p. 52 oC. 1H NMR (400 MHz, CDCl3): δ = 1.43 (s, 6H, 
CH3),1.44 (s, 6H, CH3), 1.78 (s, NH) 2.37 (s, 3H, CH3), 6.93 (s, 1H, Ar-H), 
7.01 (d, 1H, J = 7.6 Hz, Ar-H), 7.06 (d, 1 H, J = 7.6, Ar-H). 13C NMR (100 
MHz, CDCl3): δ = 21.3, 31.9, 32.0, 62.5, 62.6, 121.2, 122.0, 128.0, 136.8, 
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146.0, 149.0. HRMS (ES): m/z (%) = 190 (25, MH+). Calcd. for C13H19N 
[MH+]: 190.1596; found 190.1590.  
 
1,1,3,3,5-Pentamethylisoindol-2-yloxyl (16) 
m-Chloroperoxybenzoic acid (5.02 g, 17.21 mmol, 1.2 equiv., 77%) was 
added to an ice-cooled solution of 1,1,3,3,5-pentamethylisoindoline 15 
(2.72 g, 14.35 mmol, 1.0 equiv.) in methylene chloride (80 mL). The 
resulting solution was stirred for 1 h at 0 oC and then at room temperature 
for a further 3 h. Excess methylene chloride was added to dissolve the 
precipitate which formed during the reaction. The bright yellow organic 
phase was washed successively with HCl (0.5 M aqueous solution), NaOH 
(2 M aqueous solution) and brine, dried over anhydrous Na2SO4 and filtered. 
The filtrate was concentrated in vacuo to obtain compound 16 as a bright 
yellow solid (2.78 g, 96%). m.p. 90 oC. HRMS (ES): m/z (%) = 227 (40, 
MNa+). Calc. for C13H18NNaO [MNa+]: 227.1286; found 227.1290.  
 
2-Acetoxy-1,1,3,3,5-pentamethylisoindoline (17) 
A mixture of 1,1,3,3,5-pentamethylisoindol-2-yloxyl 16 (1.0 g, 4.90 mmol, 
1 equiv.) and palladium (130 mg, 122 umol, 0.025 equiv., 10% on carbon) 
in dry THF (25 mL) was stirred under a balloon of hydrogen gas for 20 
min. The reaction mixture was then cooled to 0oC and Et3N (1.37 mL, 9.79 
mmol, 2.0 equiv.) and AcCl (869 μL, 12.24 mmol, 2.5 equiv.) were added 
dropwise. The resulting solution was stirred at 0 oC for 30 min. and then at 
room temperature for a further 1 h. The mixture was then filtered through 
Celite and concentrated in vacuo. The residue was dissolved in EtOAc and 
washed with water and brine. The organic phase was dried over anhydrous 
Na2SO4 and filtered. The filtrate was concentrated in vacuo to give 
compound 17 as a white solid (1.18 g, 97%). m.p. 113 oC. 1H NMR (400 
MHz, CDCl3): δ = 1.38 (br s, 6H, 2 × CH3), 1.47 (br s, 6H, 2 × CH3), 2.21 
(s, 3H, CH3), 2.39 (s, 3H, CH3), 6.93 (s, 1H, Ar-H), 7.00 (d, 1H, J = 8.0 Hz, 
Ar-H), 7.07 (d, 1H, J = 8.0 Hz, Ar-H). 13C NMR (100 MHz, CDCl3): δ = 
19.3, 21.5, 25.4, 28.9, 68.0, 68.2, 121.3, 122.1, 128.5, 137.4, 141.0, 143.9, 
171.9. HRMS (ES): m/z (%) = 248 (95, MH+). Calc. for C15H23NO2 [MH+]: 
248.1651; found 248.1645. ATR-FTIR: vmax= 1758 (s, C=O).  
 
2-Acetoxy-1,1,3,3-tetramethylisoindoline-5-carboxylic acid (18) 
A solution containing 2-acetoxy-1,1,3,3,5-pentamethylisoindoline 17 (690 
mg, 2.79 mmol, 1.0 equiv.), MgSO4 (169 mg, 1.39 mmol, 0.5 equiv.) and 
freshly prepared aqueous KMnO4 solution (27.6 mL, 11.16 mmol, 4.0 
equiv., 0.4 M) was stirred at 70 oC for 1 d. The reaction mixture was cooled 
to room temperature, treated with iPrOH (10 mL) and stirred overnight. The 
mixture was filtered through Celite and the solvent removed in vacuo. The 
resulting residue was dissolved in EtOAc, washed successively with water 
and brine and dried over anhydrous Na2SO4. The solution was filtered and 
the filtrate concentrated in vacuo. Purification of the resulting residue by 
silica gel flash chromatography (eluent: CHCl3 to CHCl3/EtOAc, 9:1) gave 
18 as pale yellow solid (498 mg, 65%). m.p. 129 oC. 1H NMR (400 MHz, 
CDCl3): δ = 1.45 (br s, 6H, 2 × CH3),1.54 (br s, 6H, 2 × CH3), 2.23 (s, 3H, 
CH3), 7.25 (d, 1H, J = 7.6 Hz, Ar-H), 7.91 (s, 1H, Ar-H), 8.06 (d, 1H, J = 
7.6 Hz, Ar-H). 13C NMR (100 MHz, CDCl3): δ = 19.3, 25.2, 25.3, 28.7, 
28.9, 68.2, 68.4, 121.9, 123.8, 129.4, 130.4, 144.6, 150.2, 171.5, 171.7. 
HRMS (ES): m/z (%) = 278 (89, MH+). Calc. for C15H20NO4 [MH+]: 
278.1392; found 278.1383. ATR-FTIR: vmax= 3400-2800 (m, br, O-H), 
2771 (s, C=O), 1686 (s, C=O).  
 
5-Carboxy-1,1,3,3-tetramethylisoindol-2-yloxyl (1) from 18 
2-Acetoxy-1,1,3,3-tetramethylisoindoline-5-carboxylic acid 16 (100 mg, 
360 umol) was stirred in solution of NaOH (3 mL, 1 M) and EtOH (0.6 mL) 
at 0 oC for 30 min. The cooling bath was removed and the reaction was 
stirred at room temperature overnight. The aqueous layer was diluted with 
water (5 mL) and washed with Et2O and then acidified to pH 1 with HCl (2 
M). The acidic aqueous layer was extracted with Et2O (3 × 5 mL) and the 
combined organic layers washed with brine, dried over anhydrous Na2SO4 
and filtered. The filtrate was concentrated in vacuo and recrystallised from 
MeCN to give 1 as a yellow solid (82 mg, 97%). m.p. 211 oC (Lit. 214-218 
oC).[1b] 
 
Supporting Information: Experimental procedures for compounds 8 
and 14; 1H and 13C NMR spectra for compounds 8, 14, 15, 17 and 18; 
HPLC chromatograms for compounds 1, 9 and 14-17. 
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 Synthetic methods 
Several synthetic approaches to an 
important water-soluble nitroxide 
antioxidant are described. Each 
provides the final product in 
comparable overall yield, however the 
copper mediated cyanation of the aryl 
halide followed by hydrolysis employs 
the fewest steps with the greatest 
convenience.  
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5-Cyano-1,1,3,3-tetramethylisoindoline (8) 
 
A solution of 5-bromo-1,1,3,3-tetramethylisoindoline 5 (500 mg, 1.97 mmol, 1 equiv.), 
K4[Fe(CN)6].3H2O (207.5 mg, 984 umol, 0.25 equiv.), CuI (45 mg, 472 umol, 0.12 equiv.) and 1-
butylimidazole (825 μL, 3.934 mmol, 2 equiv.) in o-xylene (5 mL) was degassed and heated at 180oC in 
a sealed tube for 4 d. Upon cooling, the mixture was diluted with ethyl acetate and filtered. The filtrate 
was washed with NaOH (2 M aqueous solution) and brine, and dried over anhydrous Na2SO4. The 
organic phase was filtered and concentrated in vacuo. The resultant residue was subjected to purification 
via flash silica gel chromatography (EtOAc) to yield the desired compound as a mixture with the 1-
butylimidazole complex (458 mg) which was used in subsequent step without further purification. 1H 
NMR (CDCl3, 400 MHz): δ = 1.46 (s, 12H, 4 × CH3), 1.71 (br s, 1H, NH), 7.20 (d, 1H, J = 7.6 Hz, ArH), 
7.40 (s, 1H, ArH), 7.53 (d, 1H, J = 7.6 Hz, ArH). 13C NMR (CDCl3, 100 MHz): δ = 31.6, 31.8, 62.8, 63.2, 
111.0, 119.3, 122.5, 125.6, 131.5, 150.1, 154.2. HRMS (ES): m/z (%) = 201 (65, MH+) Calc. for 
C13H17N2 [MH+]: 201.1392; found 201.1317. ATR-FTIR: vmax= 3321 (w, N-H), 2226 (m, s, C≡N).  
 
Synthesis of N-benzyl-1,1,3,3,5-pentamethylisoindoline (14) 
A solution of 2-benzyl-5-methylphthalimide 13 (55.83 g, 222.2 mmol, 1.0 equiv.) in anhydrous toluene 
(500 mL) was added slowly to a freshly prepared methylmagnesium iodide solution [prepared from 
methyl iodide (83 mL, 1.33 mol, 6.0 equiv.) and magnesium turnings (40 g, 1.55 mol, 7.0 equiv)] in 
anhydrous diethyl ether (500 mL). The diethyl ether was then removed via a Dean-Stark apparatus and 
the reaction mixture heated at reflux at 110 oC for 4 h. Upon cooling, the mixture was filtered through 
Celite and washed several times with excess hexane. Air was bubbled through the filtrate overnight and 
the resulting residue was passed through a short basic alumina column (eluent: hexane). Concentration of 
the resulting filtrate in vacuo afforded compound 14 as a white solid which was recrystallized from 
methanol or pentane (15.67 g, 34%). m.p. 51 oC. 1H NMR (400 MHz, CDCl3): δ = 1.30 (s, 6H, 
CH3),1.31 (s, 6H, CH3), 2.39 (s, 3H, CH3), 4.00 (s, 2H, CH2), 6.96 (s, 1H, Ar-H), 7.06 (q, 2H, J = 7.68 
Hz, Ar-H), 7.20 - 7.25 (m, 1H, Ar-H) 7.27 - 7.32 (m, 3H, Ar-H) 7.48 (d, 2H, J = 7.37 Hz, Ar-H). 13C 
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NMR (100 MHz, CDCl3): δ = 21.4, 28.4, 28.5, 46.3, 64.0, 65.1, 121.1, 122.0, 126.4, 127.7, 127.9, 128.3, 
136.4, 143.5, 145.1, 148.0. HRMS (ES): m/z (%) = 281 (100, [M+2H]+), Calc. for C20H27N [M+2H]+: 
281.2143; found 281.2390. ATR-FTIR: vmax= 3290 (w, Ar C-H). 
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Figure S1. 1H NMR spectrum (400 MHz, CDCl3) for 5-cyano-1,1,3,3-tetramethylisoindoline 8. 
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Figure S2. 1H NMR spectrum (400 MHz, CDCl3) for N-benzyl-1,1,3,3,5-pentamethylisoindoline 14. 
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Figure S3. 1H NMR spectrum (400 MHz, CDCl3) for 1,1,3,3,5-pentamethylisoindoline 15. 
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Figure S4. 1H NMR spectrum (400 MHz, CDCl3) for 2-acetoxy-1,1,3,3,5-pentamethylisoindoline 17 
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Figure S5. 1H NMR spectrum (400 MHz, CDCl3) for 5-carboxy-1,1,3,3-tetramethylisoindol-2-yloxyl 18. 
 
 
Submitted to the European Journal of Organic Chemistry 14
Figure S6. 13C NMR spectrum (100 MHz, CDCl3) for 5-cyano-1,1,3,3-tetramethylisoindoline 8. 
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Figure S7. 13C NMR spectrum (100 MHz, CDCl3) for N-benzyl-1,1,3,3,5-pentamethylisoindoline 14. 
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Figure S8. 13C NMR spectrum (100 MHz, CDCl3) for 1,1,3,3,5-pentamethylisoindoline 15. 
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Figure S9. 13C NMR spectrum (100 MHz, CDCl3) for 2-acetoxy-1,1,3,3,5-pentamethylisoindoline 17. 
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Figure S10. 13C NMR spectrum (100 MHz, CDCl3) for 5-carboxy-1,1,3,3-tetramethylisoindol-2-yloxyl 
18.  
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Figure S11. HPLC chromatogram for 5-carboxy-1,1,3,3-tetramethylisoindol-2-yloxyl 1. 
 
 
 
 
 
 
Figure S12. HPLC chromatogram for 5-cyano-1,1,3,3-tetramethylisoindol-2-yloxyl 9. 
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Figure S13. HPLC chromatogram for N-benzyl-1,1,3,3,5-pentamethylisoindoline 14. 
 
 
 
 
 
 
 
Figure S14. HPLC chromatogram for 1,1,3,3,5-pentamethylisoindoline 15. 
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Figure S15. HPLC chromatogram for 1,1,3,3,5-pentamethylisoindol-2-yloxyl 16. 
 
 
 
 
 
 
Figure S16. HPLC chromatogram for 2-acetoxy-1,1,3,3,5-pentamethylisoindoline 17. 
 
 
 
	
